Latest Circulating Tumor Cell Stories
The presence of circulating tumor cells in the blood appears to have no relationship to survival in women who have just been diagnosed with inflammatory breast cancer.
The removal of rare tumor cells circulating in the blood might be possible with the use of biomolecules bound to dendrimers, highly branched synthetic polymers, which could efficiently sift and capture the diseased cells.
SAN DIEGO, July 28, 2011 /PRNewswire/ -- Biocept, Inc., an advanced diagnostic CLIA-certified service laboratory developing novel tests for the oncology community, today announced the availability of OncoCEE-BR(TM) for breast cancer, a test designed to detect circulating tumor cells (CTCs) found in the blood of patients with this disease, and to assess their HER2/neu status by fluorescence in situ hybridization (FISH) performed on the CTCs detected in the blood.
SAN DIEGO, July 15, 2011 /PRNewswire/ -- Biocept, Inc. announced today that it has appointed William G. Kachioff as Senior Vice President, Finance and Chief Financial Officer. As CFO, Mr.
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.